Patent Assignment
Reel/Frame 068277/0035
Assignment of Assignor's Interest
Recorded: 2024-08-14
Pages: 6
Assignor
ADC THERAPEUTICS SA
Executed: 2023-01-20
Assignee
MEDIMMUNE LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, CAMBRIDGESHIRE, CB21 6GH, UNITED KINGDOM
Covered Property
(1)
Combination Therapy with an Anti-Axl Antibody-Pbd Conjugate and Nanocups
Application:
18/837,459 →
Publication:
US 2025/0152725
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 14, 2024
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: ADC THERAPEUTICS (UK) LTD
Reel/Frame 068276/0306 →
Assignment of Assignor's Interest
Aug 14, 2024
From: ADC THERAPEUTICS (UK) LTD
To: ADC THERAPEUTICS SA
Reel/Frame 068276/0575 →
Assignment of Assignor's Interest
Aug 14, 2024
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 068276/0967 →
Assignment of Assignor's Interest
Aug 14, 2024
From: WUERTHNER, JENS
To: ADC THERAPEUTICS SA
Reel/Frame 068276/0973 →
Assignment of Assignor's Interest
Aug 14, 2024
From: ROWE, CLIFF; MASIERO, MASSIMO; COVIELLO, CHRISTIAN
To: OXSONICS LIMITED
Reel/Frame 068595/0078 →
Patent Security Agreement
Dec 9, 2024
From: ADC THERAPEUTICS SA
To: BLUE OWL OPPORTUNISTIC MASTER FUND I, L.P. (FORMERLY KNOWN AS OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.)
Reel/Frame 069560/0540 →